Information  X 
Enter a valid email address

Akzo Nobel NV (0LND)

  Print      Mail a friend       Annual reports

Monday 18 June, 2007

Akzo Nobel NV

Akzo confirms approach to ICI

Akzo Nobel NV
18 June 2007

18 June 2007

                     Akzo Nobel confirms approach to ICI

Akzo Nobel N.V. ('Akzo Nobel') confirms that it has approached the board of
Imperial Chemical Industries PLC ('ICI') with a view to entering into
discussions about a possible cash offer for ICI. However, the approach has been
rejected.

Akzo Nobel believes that ICI would represent a highly attractive addition to its
focused coatings and chemicals business following the announced sale of Organon
BioSciences N.V. earlier this year. Akzo Nobel will continue to evaluate all
strategic opportunities, including ICI, based on a disciplined and value-driven
approach to earnings and returns over cost of capital.

There can be no certainty that any further proposal will be made to the board of
ICI or that any offer or transaction will result.

In parallel, Akzo Nobel will continue its current share buy-back program of €1.6
bn launched on May 3, 2007 and will further evaluate tax efficient options of
returning cash to shareholders and optimizing its capital structure consistent
with its growth strategy.

A further announcement will be made if appropriate.

Enquiries
Akzo Nobel nv
Corporate Media Relations, tel. +31 26 366 43 43
Contact: Tim van der Zanden

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any
person is, or becomes, 'interested' (directly or indirectly) in one per cent. or
more of any class of 'relevant securities' of ICI, all 'dealings' in any '
relevant securities' of that company (including by means of an option in respect
of, or a derivative referenced to, any such 'relevant securities') must be
publicly disclosed by no later than 3.30 p.m. (London time) on the London
business day following the date of the relevant transaction.  This requirement
will continue until the date on which the offer becomes, or is declared,
unconditional as to acceptances, lapses or is otherwise withdrawn or on which
the 'offer period' otherwise ends.  If two or more persons act together pursuant
to an agreement or understanding, whether formal or informal, to acquire an '
interest' in 'relevant securities' of ICI, they will be deemed to be a single
person for the purposes of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant
securities' of ICI by Akzo Nobel or ICI, or by any of their respective '
associates', must be disclosed by no later than 12.00 noon (London time) on the
London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant
securities' 'dealings' should be disclosed, and the number of such securities in
issue, can be found on the Takeover Panel's website at
www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic
exposure, whether conditional or absolute, to changes in the price of
securities.  In particular, a person will be treated as having an 'interest' by
virtue of the ownership or control of securities, or by virtue of any option in
respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the
Takeover Panel's website.  If you are in any doubt as to whether or not you are
required to disclose a 'dealing' under Rule 8 of the Code, you should consult
the Panel.




                      This information is provided by RNS
            The company news service from the London Stock Exchange                     

a d v e r t i s e m e n t